Correlation Between Bio Path and Vaccinex

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Path and Vaccinex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Vaccinex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Vaccinex, you can compare the effects of market volatilities on Bio Path and Vaccinex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Vaccinex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Vaccinex.

Diversification Opportunities for Bio Path and Vaccinex

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bio and Vaccinex is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Vaccinex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccinex and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Vaccinex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccinex has no effect on the direction of Bio Path i.e., Bio Path and Vaccinex go up and down completely randomly.

Pair Corralation between Bio Path and Vaccinex

Given the investment horizon of 90 days Bio Path Holdings is expected to generate 1.2 times more return on investment than Vaccinex. However, Bio Path is 1.2 times more volatile than Vaccinex. It trades about -0.05 of its potential returns per unit of risk. Vaccinex is currently generating about -0.07 per unit of risk. If you would invest  3,200  in Bio Path Holdings on August 25, 2024 and sell it today you would lose (3,118) from holding Bio Path Holdings or give up 97.44% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Bio Path Holdings  vs.  Vaccinex

 Performance 
       Timeline  
Bio Path Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Path Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Vaccinex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Bio Path and Vaccinex Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Path and Vaccinex

The main advantage of trading using opposite Bio Path and Vaccinex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Vaccinex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccinex will offset losses from the drop in Vaccinex's long position.
The idea behind Bio Path Holdings and Vaccinex pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device